Physician profile
Pierre Rojas
NPI 1780945105
$288.80
in general payments reported to CMS, 2019-2025
12 companies · $39.58 in 2025
The $39.58 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.28 · 2020: $15.98 · 2021: $45.91 · 2022: $15.86 · 2023: $102 · 2024: $21.25 · 2025: $39.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $108.91 | 2023-2024 | Botox |
| Globus Medical, INC. | $24.76 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $23.96 | 2019 | |
| Nevro Corp. | $17.29 | 2021 | |
| Dermira, INC. | $15.98 | 2020 | |
| Siemens Medical Solutions USA, INC. | $15.86 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.03 | 2021 | |
| Merz Pharmaceuticals, LLC | $14.82 | 2025 | Xeomin |
| Vertos Medical, INC. | $14.28 | 2023 | Mild Device Kit |
| Allergan, INC. | $13.59 | 2021 | |
| Orthogenrx INC. | $12.90 | 2019 | |
| Stimwave Technologies Incorporated | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.